Google Health Manager Discusses User Feedback


By Neil Versel, contributing editor

November 4, 2008 | Google Health product manager Roni Zeiger remains highly optimistic about the fledgling but high-profile personal health record (PHR) service and data-aggregation platform, but is trying to assuage concerns about consumer privacy and tamp down expectations that the Internet search leader might be able to cure all that ails health care.

“A PHR and platform is necessary but not sufficient,” Zeiger says, echoing the words of national health-IT coordinator Robert Kolodner. (See “Kolodner et al Remain Optimistic for Health 2.0.”) Zeiger spoke to Digital HealthCare & Productivity shortly after appearing on stage with Kolodner and others at a health 2.0 conference in San Francisco. According to Zeiger, there have to be regular and secure data feeds from multiple sources, including physician and hospital electronic health records (EHRs), insurance companies, laboratories, and pharmacies.

Zeiger says that feedback from test users, largely based on a three-month trial with the Cleveland Clinic that ended in August, has been “surprising that it’s consistently supportive.” However, the chief complaint, according to Zeiger, is that users say, “I want to be able to get my data.” He also says consumers have consistently given him a single message: “We want more.”

Anecdotally, patients have regularly been asking doctors for electronic access to personal health information, something that runs counter to the deeply ingrained culture in medicine.

There also remains skepticism about a company like Google having access to such sensitive information. Zeiger says Google Health doesn’t have any plans to put ads on its pages, reiterating the promise made by Google chief executive Eric Schmidt at the 2008 Healthcare Information and Management Systems Society (HIMSS) conference. (See “Google CEO Discusses Google Health.”)

Zeiger says Google Health is being built on two fundamentals: transparency and choice. “We promise that we won’t sell their data, ever,” he says. This runs counter to Google’s corporate strategy of monetizing Internet search results, but Schmidt said Feb. 28 that he expects Google Health to drive users to other, revenue-producing Google services, including the main search engine.

“We won’t share their data unless they tell us it’s OK,” Zeiger adds. He notes that the company has published privacy and security guidelines that Google Health partners must follow. The focus is squarely on consumer control of data, based on opt-in consent.

Google Health also touts a recent partnership with PDX Inc. (Fort Worth, Texas), a company that aggregates data for about 65 pharmacy chains so they can share prescription information in real time. PDX provides patients with medication records through its pharmacy customers and its rx.com Web portal. The company is making prescription data available for import into Google Health, starting with customers of the New York City-based Duane Reade pharmacy chain.

“Fifty million-plus people will be able to access their medication histories in ways that weren’t possible before,” Zeiger says. That is a while off, however. Right now, Google Health’s role is “helping to build the pipes” for interoperable data exchange.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.